日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mitochondrial dysfunction in age-related sarcopenia: mechanistic insights, diagnostic advances, and therapeutic prospects

线粒体功能障碍与年龄相关性肌肉减少症:机制见解、诊断进展和治疗前景

Huang, Yingtao; Wang, Chenchen; Cui, Haijian; Sun, Guangjiang; Qi, Xiaonan; Yao, Xiaosheng

Exploring Immunological Determinants and Constructing a Predictive Model for for Diagnosis of Gout: Insights Into Immune Biomarkers.

探索痛风的免疫学决定因素并构建痛风诊断的预测模型:对免疫生物标志物的深入了解。

Zeng Huanhuan, Zheng Liqiang, Wu Dan, Yu Xiang, Zhang Guangjiang, Du Jinwan

Associations of ω-3, ω-6 polyunsaturated fatty acids intake and ω-6: ω-3 ratio with systemic immune and inflammatory biomarkers: NHANES 1999-2020

ω-3、ω-6多不饱和脂肪酸摄入量及ω-6:ω-3比值与全身免疫和炎症生物标志物的相关性:NHANES 1999-2020

Li, Yifan; Tang, Hao; Yang, Xiaotong; Ma, Lili; Zhou, Hangqi; Zhang, Guangjiang; Chen, Xin; Ma, Lijun; Gao, Jing; Ji, Wei

Correlation of Circulating Complement Levels with Clinical Characteristics of Patients with Diabetic Retinopathy

循环补体水平与糖尿病视网膜病变患者临床特征的相关性

Wang, Guangjiang; Guo, Yuan

Design and optimization of THz coupling in zirconia MAS rotors for dynamic nuclear polarization NMR

用于动态核极化核磁共振的氧化锆MAS转子中太赫兹耦合的设计与优化

Li, Guangjiang; Dastrup, Blake; Palani, Ravi Shankar; Shapiro, Michael A; Jawla, Sudheer K; Griffin, Robert G; Nelson, Keith A; Temkin, Richard J

Application of SHEL Model in the Management of Respiratory Tract Exposure in Fangcang Shelter Hospitals for COVID-19

SHEL模型在方舱医院新冠肺炎呼吸道暴露管理中的应用

Wu, Xiulian; Wang, Xin; Guo, Huimin; Zhang, Lili; Wu, Guangjiang

Measurement of Time Dependent Reflection, Transmission, and Absorption in Laser Driven Silicon and GaAs Switches for 250 GHz Radiation

测量激光驱动硅和砷化镓开关在250 GHz辐射下的时间相关反射、透射和吸收

Li, Guangjiang; Claveau, Elliot L; Jawla, Sudheer K; Schaub, Samuel C; Shapiro, Michael A; Temkin, Richard J

Hepatic interferon regulatory factor 8 expression suppresses hepatocellular carcinoma progression and enhances the response to anti-programmed cell death protein-1 therapy

肝脏干扰素调节因子8的表达抑制肝细胞癌的进展并增强对程序性死亡蛋白-1抑制剂治疗的反应。

Wu, Hongxi; Li, Yan; Shi, Guangjiang; Du, Shijia; Wang, Xiaobin; Ye, Wanli; Zhang, Zixuan; Chu, Ya; Ma, Shuqian; Wang, Dajia; Li, Yuan; Chen, Zhen; Birnbaumer, Lutz; Wang, Zhuo; Yang, Yong

A novel inhibitor of ARfl and ARv7 induces protein degradation to overcome enzalutamide resistance in advanced prostate cancer

ARfl 和 ARv7 的新型抑制剂可诱导蛋白质降解以克服晚期前列腺癌中的恩杂鲁胺耐药性

Yan Li, Ya Chu, Guangjiang Shi, Xiaobin Wang, Wanli Ye, Chun Shan, Dajia Wang, Di Zhang, Wei He, Jingwei Jiang, Shuqian Ma, Yuhong Han, Zhili Zhao, Shijia Du, Zhen Chen, Zhiyu Li, Yong Yang, Chen Wang, Xi Xu, Hongxi Wu

Loss of a Negative Feedback Loop between IRF8 and AR Promotes Prostate Cancer Growth and Enzalutamide Resistance

IRF8 和 AR 之间负反馈回路的丧失促进了前列腺癌的生长和恩杂鲁胺的耐药性

Hongxi Wu #, Linjun You #, Yan Li #, Zhili Zhao #, Guangjiang Shi, Zhen Chen, Zhuo Wang, Xianjing Li, Shijia Du, Wanli Ye, Xiaofang Gao, Jingjing Duan, Yan Cheng, Weiyan Tao, Jinsong Bian, Jin-Rong Zhou, Qingyi Zhu, Yong Yang